Blue dye gel shows promise for treating inoperable skin cancer
NCT ID NCT07311057
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tests whether a blue dye gel (methylene blue) can shrink skin cancer tumors and help wounds heal in people with advanced squamous cell carcinoma who cannot have surgery or radiation. About 20 adults with small, multiple skin cancer lesions will apply the gel every two days for a month, followed by a healing gel. Researchers will track tumor size and safety for six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCC - SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mashhad University of Medical Sciences
Mashhad, Razavi Khorasan Province, Iran
Conditions
Explore the condition pages connected to this study.